最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/9/29。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 58
- 預計賣出市值
- $1.58 億
- 賣方
- 14
- 公司
- 1
- 依 10b5-1 計畫
- 55
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | 2026/8/2716:46 ET | Bruce I. Sachs董事 | 1,210 | $66.3 萬 | 2026/8/27 | Goldman Sachs & Co. LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/7/216:30 ET | Tatsis Ourania高階主管 | 1,500 | $78.7 萬 | 2026/7/210b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/7/214:16 ET | McKechnie Duncan高階主管 | 1,541 | $80.0 萬 | 2026/7/210b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/7/113:00 ET | Liu Joy高階主管 | 828 | $41.6 萬 | 2026/7/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/6/2609:54 ET | Bozic Carmen高階主管 | 596 | $28.8 萬 | 2026/6/2610b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/6/1811:33 ET | Bozic Carmen高階主管 | 1,020 | $47.1 萬 | 2026/6/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/6/1515:07 ET | Bozic Carmen高階主管 | 4,062 | $182.8 萬 | 2026/6/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/6/514:33 ET | Bozic Carmen高階主管 | 1,745 | $78.5 萬 | 2026/6/510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/6/114:13 ET | Liu Joy高階主管 | 828 | $36.4 萬 | 2026/6/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/2913:31 ET | Bozic Carmen高階主管 | 1,974 | $88.8 萬 | 2026/5/2910b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/1510:41 ET | Bozic Carmen高階主管 | 1,354 | $61.4 萬 | 2026/5/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/1510:02 ET | Bunnage Mark E.高階主管 | 33 | $1.50 萬 | 2026/5/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/1213:11 ET | Bozic Carmen高階主管 | 6,988 | $314.5 萬 | 2026/5/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/614:13 ET | Biller Jonathan高階主管 | 5,193 | $220.3 萬 | 2026/5/6 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/410:18 ET | Bhatia Sangeeta N.董事 | 318 | $13.5 萬 | 2026/5/410b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/5/114:28 ET | Liu Joy高階主管 | 1,104 | $46.9 萬 | 2026/5/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/4/113:02 ET | Liu Joy高階主管 | 978 | $43.9 萬 | 2026/4/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/3/2710:32 ET | Bozic Carmen高階主管 | 2,329 | $105.0 萬 | 2026/3/2710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/3/1311:38 ET | Bozic Carmen高階主管 | 2,329 | $112.2 萬 | 2026/3/1310b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/3/1109:44 ET | McKechnie Duncan高階主管 | 2,633 | $131.2 萬 | 2026/3/1110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/3/410:09 ET | McKechnie Duncan高階主管 | 2,437 | $115.8 萬 | 2026/3/410b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/3/217:09 ET | Liu Joy高階主管 | 892 | $44.2 萬 | 2026/3/210b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2716:41 ET | Kewalramani Reshma高階主管 · 董事 | 4.00 萬 | $1,974 萬 | 2026/2/2710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2709:50 ET | Bozic Carmen高階主管 | 2,329 | $111.9 萬 | 2026/2/2710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2511:28 ET | McKechnie Duncan高階主管 | 4,910 | $239.4 萬 | 2026/2/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2511:12 ET | Tatsis Ourania高階主管 | 260 | $12.6 萬 | 2026/2/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2511:02 ET | Bunnage Mark E.高階主管 | 620 | $30.2 萬 | 2026/2/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2510:35 ET | Atkinson Edward Morrow III高階主管 | 668 | $32.5 萬 | 2026/2/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2510:06 ET | Sachdev Amit高階主管 | 1,846 | $89.8 萬 | 2026/2/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/2509:41 ET | Biller Jonathan高階主管 | 945 | $46.0 萬 | 2026/2/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1916:18 ET | Sachdev Amit高階主管 | 5.86 萬 | $2,748 萬 | 2026/2/1910b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1812:28 ET | Tatsis Ourania高階主管 | 368 | $17.4 萬 | 2026/2/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1810:46 ET | Biller Jonathan高階主管 | 1,244 | $58.9 萬 | 2026/2/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1810:17 ET | Bunnage Mark E.高階主管 | 1,182 | $56.0 萬 | 2026/2/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1809:55 ET | Atkinson Edward Morrow III高階主管 | 817 | $38.7 萬 | 2026/2/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1715:26 ET | Bunnage Mark E.高階主管 | 2,437 | $119.3 萬 | 2026/2/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1714:34 ET | Tatsis Ourania高階主管 | 609 | $29.8 萬 | 2026/2/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1713:52 ET | Biller Jonathan高階主管 | 2,476 | $121.2 萬 | 2026/2/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1713:20 ET | Atkinson Edward Morrow III高階主管 | 2,031 | $99.4 萬 | 2026/2/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1314:59 ET | Biller Jonathan高階主管 | 988 | $49.3 萬 | 2026/2/1310b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1314:54 ET | Bhatia Sangeeta N.董事 | 266 | $13.3 萬 | 2026/2/1310b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1314:43 ET | Tatsis Ourania高階主管 | 1,500 | $75.0 萬 | 2026/2/1310b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1111:30 ET | Biller Jonathan高階主管 | 1,925 | $88.6 萬 | 2026/2/1110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1110:58 ET | Atkinson Edward Morrow III高階主管 | 1,751 | $80.6 萬 | 2026/2/1110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1110:18 ET | Bunnage Mark E.高階主管 | 2,021 | $93.1 萬 | 2026/2/1110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/2/1109:47 ET | Tatsis Ourania高階主管 | 466 | $21.5 萬 | 2026/2/1110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/1/710:31 ET | Tatsis Ourania高階主管 | 4,500 | $213.7 萬 | 2026/1/710b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2026/1/611:16 ET | Wagner Charles F Jr高階主管 | 9,532 | $439.4 萬 | 2026/1/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| VRTXVertex Pharmaceuticals Inc | 2025/12/316:34 ET | Jeffrey M Leiden董事 · 高階主管 | 6.38 萬 | $2,763 萬 | 2025/12/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| VRTXVertex Pharmaceuticals Inc | 2025/12/313:01 ET | Wagner Charles F Jr高階主管 | 7,000 | $322.7 萬 | 2025/12/310b5-1 | Fidelity Brokerage Services LLC | SEC |